CogenDx has launched its newest test offering, DxWound. The test uses DNA-based technology to provide sensitive detection of an array of microbes, including aerobic and anaerobic bacteria, fungi, and antibiotic resistance genes. Test results equip clinicians to rapidly and accuratley identify pathogens causing infections and choose antibiotics with improved likelihood for success. DxWound utilizes a swab to collect microbial DNA directly from the infection site and leverages a transport buffer that preserves the wound microbiome during specimen transit. Test results are delivered the next business day from specimen receipt at the laboratory.